June 30th 2025
A new functional classification can help achieve precise vision goals
Community Practice Connections™: Novel Therapies for Neovascular Retinal Disease – Expert Analysis of New Key Data
View More
Practical Approaches to Modern Dry Eye Treatment and Management
June 25, 2025
Register Now!
Latest Advances in X-Linked Retinitis Pigmentosa: Optimizing Diagnosis and Developments in Gene Therapy
View More
Cases & Conversations™: Real World Review of Treat and Extend Strategies for Neovascular Retinal Disease
View More
Community Practice Connections™: Innovations and Interdisciplinary Approaches in Glaucoma Management—Expanding the Treatment Arsenal (CME Track)
View More
Community Practice Connections™: Innovations and Interdisciplinary Approaches in Glaucoma Management—Expanding the Treatment Arsenal (COPE Track)
View More
Road Mapping the Treat-and-Extend Protocol in nAMD and DME – When Time Is Sight (CME Track)
View More
Road Mapping the Treat-and-Extend Protocol in nAMD and DME – When Time Is Sight (COPE Track)
View More
Burst CME Plus™ - Unveiling Pharmacological Advances in nAMD & DME: From Durability to Applicability
View More
Community Practice Connections™: Navigating Complexities in Neurotrophic Keratitis — A Roadmap for Advanced Patient Care (CME Credit)
View More
Community Practice Connections™: Navigating Complexities in Neurotrophic Keratitis — A Roadmap for Advanced Patient Care (COPE Credit)
View More
Retina Specialists: Join us in Long Beach
July 31, 2025 - August 2, 2025
Register Now!
SimulatED™: Pioneering Treat-and-Extend Therapy—The Impact of Early Application
View More
Rapid Reviews in Retina™: Emerging Updates from Summer 2024 - Addressing the Wealth of New Data in Treatments for nAMD and DME
View More
3rd Annual IKA Keratoconus Symposium: Front to Back and Everything in Between
September 6, 2025
Register Now!
Clinical Consultations™: Novel Therapeutic Targets in Neovascular Retinal Diseases – A Focus on the Roles of VEGF-C/D
View More
EyeCon 2025
September 26-27, 2025
Register Now!
Optometrists: Earn COPE CE Credits in Portland or Virtually
October 16-17, 2025
Register Now!
Join us at The Ophthalmology Meeting in Orlando this October
October 18, 2025
Register Now!
Rapid Reviews in Retina™: Emerging Updates from Winter 2024 – Addressing the Wealth of New Data in Treatments for nAMD and DME (Cope Credit)
View More
Rapid Reviews in Retina™: Emerging Updates from Winter 2024 – Addressing the Wealth of New Data in Treatments for nAMD and DME (CME Track)
View More
Community Practice Connections™: Transforming Treatment in nAMD, DME, and DR – Keeping an Eye on Optimal Outcomes
View More
(CME) Optimizing Management of Ocular Toxicity in Cancer Patients: The Role of Ophthalmologists in the Spectrum of Care
View More
(COPE) Optimizing Management of Ocular Toxicity in Cancer Patients: The Role of Ophthalmologists in the Spectrum of Care
View More
Expert Perspectives on Technological Advances in Cataract Surgery
View More
Expanding Treatment Options for Demodex Blepharitis: Patient-Centric Approaches to Therapy
View More
Burst CME™ Part 3: Initiating Early Intervention in Patients With Glaucoma Who Fail Pharmacological Therapy
View More
(CME Credit) Community Practice Connections™: Applying Advances in Neovascular Retinal Disease - Expanding Treatment Intervals & Enhancing Outcomes
View More
Interventional Glaucoma Treatment: Evolving Paradigms for Addressing Unmet Needs
View More
(CME Track) Burst CME™ Part 1: Insights Into Glaucoma and the Need for Early Intervention
View More
Microincision IOLs go head-to-head
April 1st 2008Nowadays, cataract surgery not only has a therapeutic purpose, which is to substitute an opaque lens with a transparent IOL, but it also has a refractive aim; to correct previous refractive defects in order to eliminate the use of spectacles. The need for a good postoperative visual acuity and a fast functional recovery has lead cataract surgery to become more and more micro-invasive in nature so that surgical trauma is reduced, a faster recovery and good, time-stable visual results are achieved.1 The achievement of this goal has been realized, thanks to the improvement of surgical techniques, in the form of microcoaxial phacoemulsification and bimanual microphacoemulsification,2 which now allow the almost complete reduction of surgically induced astigmatism.
We have microincisions & now we have a suitable IOL
April 1st 2008I have been so impressed with the aspheric optics and good centration of the Akreos MI60 that I use it as my first choice for implantation; including in patients with visual-critical occupations such as aviators and air traffic controllers
ESCRS study has little impact on US practice
April 1st 2008Results of the European Society of Cataract and Refractive Surgeons (ESCRS) study of endophthalmitis prophylaxis do not appear to have had a significant impact on the practices of US cataract surgeons, according to the findings of an online survey conducted by the American Society of Cataract and Refractive Surgery (ASCRS) Cataract Clinical Committee.1 The survey results were reported by David F. Chang, MD, at the Spotlight on Cataracts 2007 symposium held during the annual meeting of the American Academy of Ophthalmology.
Computer model provides vital information about lens accommodation
April 1st 2008During accommodation, changes in lens thickness are mainly caused by deformation of the nucleus. In older, non-accommodating lenses, the deformations occur predominantly in the equatorial region and do not affect the central curvatures of the lens, according to a report published online ahead of print by Acta Ophthalmologica.
Iris registration is a good compensator of cyclotorsion
March 31st 2008Compensation of cyclotorsion using iris registration can be helpful in decreasing misalignment of the axis of correction and in improving the overall outcome of LASIK, according to a study to be published in the April 2008 issue of the Journal of Cataract & Refractive Surgery.
Cataract incision size is just right thanks to new technology
March 10th 2008Incision sizes needed to remove cataracts have been significantly reduced by new technology, such as the vision enhancement system (Stellaris; Bausch & Lomb) which allows surgeons to make two 1.8 mm cuts on either side of the eye.
Resistance fuelling contact lens infections
March 4th 2008A study published in the January issue of Antimicrobial Agents & Chemotherapy, has found that the high proportion of corneal infections linked to contact lens solutions are fuelled and made resistant to treatment by the formation of a highly resistant structure of microbial cells held together with a glue-like matrix material, called biofilms.